A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the ...
Roche said the late-stage trial did not provide reliable evidence that the drug's use in combination with Pfizer's Ibrance ...
The drug is sometimes prescribed to certain at-risk people—but what does the science say?
Ipsen found cases of secondary malignancies in a confirmatory study of Tavzerik, a medicine it got in a purchase of Epizyme ...
The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also said it is ...
News-Medical.Net on MSN
Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
A positive story for those going through cancer treatment. The Houston-based non-profit CanCare is stepping in to fill the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results